Spot Biosystems
Develops non-viral gene therapy using extracellular vesicle delivery platform for genetic medicines
$40MSeries B
Role not disclosedActivity from announced rounds
Develops non-viral gene therapy using extracellular vesicle delivery platform for genetic medicines